Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 31, 2018

View Archived Issues

Taisho presents safety and PK data for TS-134

Astatine-211 targeted to CD38 tested in minimal residual disease multiple myeloma models

First-in-human data for JNJ-54175446 published

Phase II results for the dissociative steroidal anti-inflammatory drug vamorolone in DMD

G0S2 is epigenetically silenced in IDH1-mutant glioma, leading to improved prognosis

Amgen develops anti-GIPR antibody

Immune cells can cause pain for brain

Inducing senescence sets off antitumor response

Innate immunity shuttles antigens to B-cell centers

Novel pyrrolopyridine analogues show human CMV-inhibitory activity by unusual mechanism of action

Novel SIRT6 allosteric activator, MDL-800, suppresses tumor growth in xenograft models of HCC

Transcription factor suppresses immunity, halts lupus in mice

Emergent BioSolutions makes FDA submission for potential emergency use of NuThrax

InventisBio and Betta Pharma sign Chinese agreement for D-0316

University of Southern California patent describes agents for imaging ADP-ribosylation

Anti-RSV compounds reported in Enanta Pharmaceuticals patent

Bristol-Myers Squibb describes formyl peptide receptor agonists

PTC Therapeutics patents compounds for Huntington's disease

Tianjin Zhongxin Pharmaceutical Research Center reports agents for treatment of cancer

National Health Research Institutes reports development of tyrosine kinase inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...